Back to Test Catalogue

Adenosine Deaminase, Erythrocyte

Test ID: ADA ERC

Test

Aliases/Synonyms

ADA Deficiency

Method

Kinetic Spectrophotometry

Specimens

Whole Blood

Clinical Utility

Adenosine Deaminase (ADA) deficiency is an autosomal recessive disorder of purine metabolism primarily affecting lymphocyte development, viability, and function. Affected individuals have less than 1 percent of normal ADA catalytic activity in red cell hemolysates. ADA deficiency is the cause of 20-30 percent of SCID cases. If the patient has been recently transfused, ADA deficiency may be masked; interpret results with caution. Heterozygotes cannot be identified by this test.

Test Location

Quest Diagnostics, California USA

Test Version

24-Jun-2022

Specimen

Specimens

Whole Blood

Collection Containers

Lavender top (EDTA); Pink top (EDTA); Green top (Li heparin)

Sample Volume

1.0 mL

Minimum Volume

1.0 mL

Collection & Handling

Handling Information

Store and send cold; do not freeze.

Stability

Ambient 15 days
Refrigerated 15 days
Frozen Not acceptable

Rejection Criteria

Hemolysis Present
Specimen Frozen

Test Version

24-Jun-2022

Performance / Interpretation

Method

Kinetic Spectrophotometry

Turnaround Time

10 days

Results

Name Units Reference Range Conversion Factor
Adenosine Deaminase mU/g Hb
  • 400 - 900

Test Location

Quest Diagnostics, California USA

Test Version

24-Jun-2022

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
ADA ERC 63375ADENOSINE DEAMINASE RBC mU/g Hb

Test Version

24-Jun-2022